# Table 4 Duration and total costs for all community-acquired RV-GE induced hospital stays in the study hospital

Age Pre-vaccination period (2002–2005) Funded vaccination period (2008–2009) Reduction
Duration of hospital stay (days) per year (mean; 95% CI) Estimated mean of total costs per year (for patients/accompanying persons) Duration of hospital stay (days) per year (mean; 95% CI) Estimated mean total costs per year (patient/accompanying person) Duration of hospital stay decreased by (%) Costs per year decreased by (%)
0–11 mos 3.4 (3.1–3.7) 224,216 €/ 7,865 € 3.0 (2.3–3.6) 29,295 €/ 1,087 € 11.8 86.9/86.2
12–23 mos 4.0 (3.6–4.3) 242,904 €/ 8,521 € 3.5 (3.4–3.5) 86,256 €/ 3,201 € 12.5 64.5/62.4
2–5 yrs 3.7 (3.6–3.9) 188,312 €/ 6,608 € 3.5 (3.1–3.8) 76,493 €/ 2,838 € 5.4 59.4/57.1
6–10 yrs 4.1 (3.7–4.4) 63,493 €/0 2.5 (1.8–3.2) 6,975 €/0 39.0 -
11–18 yrs 3.9 (2.8–4.9) 28,162 €/0 3.8 (2.7–4.8) 5,301 €/0 2.6 -
All 3.8 (3.5–4.1) 747,087 €/22,994 € 3.3 (2.7–3.8) 204,320 €/ 7,126 € 13.2 72.7/69.0
1. Calculation:
2. Pre-vaccination group: Estimated mean of total costs per year = annual mean number of patients with community-acquired RV-GE in the respective age group x mean duration of hospital stay x mean cost per patient/accompanying person.
3. Post-vaccination group: mean of total costs per year = annual mean number of patients with community-acquired RV-GE in the respective age group x mean duration of hospital stay x mean cost per patient/accompanying person.